Bio View (Israel) Today
| BIOV Stock | ILS 25.30 0.90 3.44% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Bio View is trading at 25.30 as of the 30th of November 2024, a 3.44 percent decrease since the beginning of the trading day. The stock's open price was 26.2. Bio View has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Bio View are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. The company has 13.75 M outstanding shares. More on Bio View
Moving against Bio Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bio Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bio View's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bio View or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and Pres | Alan Schwebel |
| Business Concentration | Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
Bio View (BIOV) is traded on Tel Aviv Stock Exchange in Israel and employs 35 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 53.86 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bio View's market, we take the total number of its shares issued and multiply it by Bio View's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bio View operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 13.75 M outstanding shares.
Bio View has accumulated about 17.67 M in cash with 3.25 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24.
Check Bio View Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Bio View is S53.86 Million. Bio View retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with substantial debt, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.
Check Bio Ownership Details
Bio View Risk Profiles
Although Bio View's alpha and beta are two of the key measurements used to evaluate Bio View's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.95 | |||
| Semi Deviation | 3.63 | |||
| Standard Deviation | 4.16 | |||
| Variance | 17.29 |
Bio Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bio View without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Other Information on Investing in Bio Stock
Bio View financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio View security.